Arrowhead Pharmaceuticals, Inc. (ARWR)

Arrowhead Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	3,132	2,880	3,498	6,509	4,405	2,686
Market Cap Growth	28.80%	-17.67%	-46.25%	47.77%	64.01%	59.15%
Enterprise Value	2,728	2,592	3,203	6,167	4,110	2,427
PE Ratio	-	-14.03	-19.87	-46.21	-52.09	39.51
PS Ratio	88.30	11.96	14.38	47.07	50.06	15.91
PB Ratio	6.47	10.62	8.78	15.92	9.54	10.98
P/FCF Ratio	-7.54	-8.71	-18.52	44.05	-40.88	16.68
P/OCF Ratio	-13.79	-18.72	-25.70	37.99	-45.98	15.52
EV/Sales Ratio	76.91	10.77	13.17	44.59	46.71	14.38
EV/EBITDA Ratio	-7.26	-15.10	-19.79	-46.51	-46.81	36.98
EV/EBIT Ratio	-7.00	-14.07	-18.59	-43.78	-43.85	39.66
EV/FCF Ratio	-6.68	-7.84	-16.96	41.74	-38.15	15.07
Debt / Equity Ratio	0.25	0.42	0.20	0.06	0.05	-
Debt / EBITDA Ratio	-0.28	-0.67	-0.50	-0.19	-0.24	-
Debt / FCF Ratio	-0.25	-0.35	-0.43	0.17	-0.20	-
Quick Ratio	8.03	3.83	2.72	2.58	7.78	2.67
Current Ratio	8.31	3.98	2.92	2.63	7.92	2.73
Asset Turnover	0.05	0.29	0.35	0.21	0.16	0.50
Interest Coverage	-19.47	-10.05	-	-	-	-
Return on Equity (ROE)	-147.10%	-56.20%	-42.00%	-32.30%	-17.40%	32.20%
Return on Assets (ROA)	-59.90%	-24.60%	-25.30%	-20.90%	-15.20%	20.00%
Return on Capital (ROIC)	-78.61%	-53.04%	-37.18%	-34.31%	-19.29%	24.95%
Earnings Yield	-15.03%	-7.13%	-5.03%	-2.16%	-1.92%	2.53%
FCF Yield	-15.01%	-11.48%	-5.40%	2.27%	-2.45%	6.00%
Buyback Yield / Dilution	-14.00%	-1.26%	-1.62%	-3.00%	-2.14%	-17.90%
Total Shareholder Return	-14.00%	-1.26%	-1.62%	-3.00%	-2.14%	-17.90%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).